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The dynamical properties of water in the condensed phase deviate from their
bulk values at interfaces. Here we utilize all atom molecular dynamics (MD)
simulations to characterize the dynamical properties of water present in
protein-protein interfaces. We consider specifically the complexes formed be-
tween the attachment protein of the Nipah virus (G) and its preferred human
receptors, ephrins B2 and B3. These protein-protein interactions constitute the
first step in viral infection. X-ray diffraction of these two complexes indicates
an exceptionally large amount of water crystallized in the interstitial region
between the two proteins, as compared to other protein-protein complexes.
Surprisingly despite a modest sequence identity of ~50% between the two
ephrin receptors, the dynamical properties of water in the two complexes
are qualitatively similar. Specifically, we find that the diffusion coefficients
of interstitial waters are an order to magnitude smaller than those in bulk wa-
ter. Nevertheless, while the water molecules in the interstitial region show a
tendency to occupy their crystallographic positions, their residence times in
the interstitial region are of the order of only a few hundred picoseconds.
The water molecules in the interstitial region exchange with the bulk solvent,
and only a tiny fraction (< 5%) remain trapped in the interstitial region for
more than 150 ns. In spite of the perpetual exchange with bulk media, the
interstitial waters exhibit dipole relaxation rates and hydrogen bond lifetimes
several orders in magnitude greater than bulk water. The waters in these two
interfaces, in fact, carry a statistically large dipole moment perpendicular to
the interface, which is perhaps in response to the multiple salt bridges present
in the interface. Such deviations of water properties from bulk values are
significantly different from those observed at lipid-water and protein-water
interfaces.
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Histone 3 (H3) lysine 4 (H3K4) methylation is an evolutionary conserved
epigenetic mark that is involved in the control of gene expression. Lysine res-
idues can be mono-, di-, or tri-methylated, often which each mark leading to
different outcomes. In humans, the Mixed Lineage Leukemia-1 enzyme
(MLL1, ALL1, HRX, KMT2A) is a SET1 family member that possesses
H3K4 mono-methyltransferase activity conferred by its conserved Suppressor
of Variegation, Enhancer of Zest, Trithorax (SET) domain. Di-methylation of
H3K4 requires a sub-complex of proteins including WDR5, RbBP5, Ash2L,
and DPY-30 (WRAD), which binds to MLL1 forming the MLL1 core complex.
Di-methylation of H3K4 is associated with active transcriptional states of chro-
matin. We recently demonstrated that WRAD is a novel non-SET domain
enzyme that catalyzes H3K4 di-methylation in a manner that is dependent on
a non-active site surface from MLL1. The MLL1 surface required for interac-
tion with WRAD and for H3K4 di-methylation is unknown. Genome
sequencing studies recently revealed several missense mutations that occur in
and around the SET domain in various cancers and developmental disorders.
We noticed that a subset of missense mutations associated with human Kabuki
syndrome (KS) map to a common non-active site surface in the MLL1 SET
domain with no known function. In this investigation, we substituted all KS
missense amino acid positions into MLL1 and observed that all are required
for H3K4 di-methylation by the MLL1 core complex, which is associated
with a loss of the ability of MLL1 to interact with the RbBP5-Ash2L hetero-
dimer. Our results suggest that amino acids from this surface, called the Kabuki
interaction surface or (KIS), are required for formation of the H3K4 di-
methyltransferase active site within the MLL1 core complex.
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Research Institute, Baltimore, MD, USA.Malaria has been a human life threat for centuries, particularly in tropical and
subtropical regions of the world. Nevertheless, our repertoire of medication to
treat the disease has been very limited 1, and emerging resistance of the ma-
laria parasite Plasmodium has further restricted the use of current antimalarial
treatment. The most recent reports indicating artemisinin resistance in
Cambodia2 are indeed alarming and underscore the critical importance of
exploring novel pathways for interfering with the life cycle of the malaria
parasite.
Surface plasmon resonance (SPR) has been a powerful tool to study protein
ligand interactions. We utilize this technique for fragment and small
molecule screening (~150-500 Da) to identify PPI-inhibitors or PPI-
stabilizers 3.
In this study we present the identification of PPI-inhibitors for three plasmodial
targets and two examples of PPI-stabilizers. We will furthermore demonstrate
the in vitro effect on Plasmodium falciparum cultures of these PPI-inhibitors
and PPI-stabilizers in the liver stage as well as blood stage form of the parasite.
Small-molecules derived from our studies may represent useful probes for
further dissecting the underlying biological mechanisms and analyzing the
pathways in Plasmodium and other apicomplexan species such as Toxoplasma,
Cryptosporidium, Eimeria, Theileria and Babesia. Further development of our
current small molecules may provide initial hits for lead optimization in drug
design studies.
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Isothermal titration calorimetry (ITC) is the gold standard for the quantitative
characterization of biomolecular interactions. However, reliable determination
of the dissociation constant (KD) is typically limited to the range 100 mM >
KD > 1 nM. Nevertheless, interactions characterized by a higher KD can be as-
sessed indirectly, provided that a suitable competitive ligand is available whose
KD falls within the directly accessible window. Unfortunately, the established
competitive ITC displacement method has two major limitations. First, it re-
quires the high-affinity ligand be soluble at high concentrations in aqueous
solution (typically >100 mM). This poses serious problems in quantifying
high-affinity interactions involving poorly water-soluble small-molecule li-
gands taken from compound libraries, as is usually the case in many drug-
discovery projects. A second limitation of the displacement method is that
the protocol necessitates at least two titrations to characterize one high-
affinity inhibitor. This limits the great potential of microcalorimetry both in
drug discovery efforts, where high sample throughput is required, as well as
in basic research, where precious biological samples are often available only
in limited amounts.
Here, we present two novel competition assays for measuring ultratight protein-
ligand interactions by ITC that overcome these limitations. The first assay al-
lows for a precise thermodynamic description of high-affinity protein-ligand in-
teractions involving poorly water-soluble compounds (Krainer et al. Anal.
Chem.2012, 84, 10715), while the second assay provides a simultaneous quan-
tification of both the competitive, moderate-affinity and the high-affinity ligand
in a single experiment with minimal sample requirement. We discuss the theo-
retical background of the approach and demonstrate some practical applications
using examples of high-affinity protein-ligand interactions.
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The thermodynamics associated with small-protein interactions essentially
define how drugs bind to target receptor proteins. As proteins are dynamic,
it is of importance to understand the early time (sub-millisecond) thermody-
namics and kinetics associated with small molecules binding. This time
regime presents experimental challenges in both the measurement of the
